首页|当归芍药散联合叶酸片治疗慢性萎缩性胃炎的临床疗效观察

当归芍药散联合叶酸片治疗慢性萎缩性胃炎的临床疗效观察

Clinical efficacy of Danggui Shaoyao powder combined with folic acid tablets in the treatment of chronic atrophic gastritis

扫码查看
目的 探讨当归芍药散联合叶酸片治疗慢性萎缩性胃炎的临床疗效.方法 选取浙江大学附属邵逸夫医院龙游分院2021年3月至2022年3月收治的慢性萎缩性胃炎患者90例为研究对象,采用随机对照研究方法,按照随机数字表法分为对照组(n=45),试验组(n=45);对照组采用叶酸片治疗,试验组在对照组基础上给予当归芍药散治疗,比较两组治疗前后中医证候积分、胃镜与病理评分、炎症指标水平、临床疗效.结果 试验组患者中医证候评分[反酸(0.57±0.19)分,胃脘痛(0.84± 1.36)分]降低程度均明显高于对照组[反酸(1.46±0.39)分,胃脘痛(1.52±1.41)分](t=4.86、6.52,均P<0.05);试验组患者的炎症因子水平[肿瘤坏死因子α(TNF-α)(1.03±0.11)µg/L、白细胞介素6(IL-6)(8.15±1.42)ng/L、C 反应蛋白(CRP)(6.55±0.98)mg/L]均低于对照组[TNF-α(1.73±0.14)μg/L、IL-6(12.24±1.48)ng/L、CRP(10.23±1.03)mg/L](t=4.52、7.66、6.95,均P<0.05);试验组胃镜及病理评分[肠上皮化生(0.78±0.35)分,异形增生(0.30±0.10)分]均低于对照组[肠上皮化生(1.31±0.38)分,异形增生(0.68±0.12)分](t=4.13、3.85,均P<0.05);试验组总有效率[93.33%(42/45)]高于对照组[77.78%(35/45)](x2=4.40,P<0.05).结论 对慢性萎缩性胃炎患者采用当归芍药散联合叶酸片治疗,可有效改善中医证候,降低炎症因子水平,临床效果较好.
Objective To investigate the clinical efFicacy of Danggui Shaoyao powder combined with folic acid tablets in the treatment of chronic atrophic gastritis.Methods A total of 90 patients with chronic atrophic gastritis who were treated at Longyou Branch,Sir Run Run Shaw Hospital,Zhejiang University from March 2021 to March 2022 were included in this study.They were randomly divided into a control group and an experimental group,with 45 patients per group.The control group was treated with folic acid tablets,while the experimental group was treated with Danggui Shaoyao powder combined with folic acid tablets.Before and after treatment,traditional Chinese medicine syndrome scores,gastroscopy and pathology scores,and inflammatory factor levels were compared between the two groups.Clinical efficacy was compared between the two groups.Results The amplitudes of decreases in traditional Chinese medicine syndrome score in the experimental group[acid reflux(0.57±0.19)points and epigastric pain(0.84±1.36)points]were significantly greater than those in the control group[acid reflux(1.46±0.39)points,epigastric pain(1.52±1.41)points,t=4.86,6.52,both P<0.05].Inflammatory factor levels in the experimental group[tumor necrosis factor-α(1.03±0.11)μg/L,interleukin-6(8.15±1.42)ng/L,C-reactive protein(6.55±0.98)mg/L]were significantly lower than those in the control group[tumor necrosis factor-α(1.73±0.14)μg/L,interleukin-6(12.24±1.48)ng/L,C-reactive protein(10.23±1.03)mg/L,t=4.52,7.66,6.95,all P<0.05].The gastroscopy and pathological scores in the experimental group[intestinal metaplasia(0.78±0.35)points,dysplasia(0.30±0.10)points]were significantly lower than those in the control group[intestinal metaplasia(1.31±0.38)points,dysplasia(0.68±0.12)points,t=4.13,3.85,both P<0.05].The overall response rate in the experimental group was 93.33%(42/45),which was significantly higher than 77.78%(35/45)in the control group(x2=4.40,P<0.05).Conclusion Danggui Shaoyao powder combined with folic acid tablets in the treatment of chronic atrophic gastritis can effectively improve traditional Chinese medicine syndromes,reduce the level of inflammatory factors,and have a good clinical effect.

Gastritis,atrophicDrugs,Chinese herbalGastroscopyPathologyTumor necrosis factor-alphaInterleukin-6HyperplasiaDanggui Shaoyao powderFolic acid

吴绵勇、郁银娟、邱根祥

展开 >

浙江大学附属邵逸夫医院龙游分院消化内科,衢州 324400

胃炎,萎缩性 中草药 胃镜检查 病理学 肿瘤坏死因子α 白细胞介素6 增生 当归芍药散 叶酸

2024

中国基层医药
中华医学会,安徽医科大学

中国基层医药

影响因子:1.003
ISSN:1008-6706
年,卷(期):2024.31(1)
  • 16